Arcutis Biotherapeutics (ARQT) Asset Utilization Ratio (2022 - 2026)
Arcutis Biotherapeutics' Asset Utilization Ratio was 0.98 in Q2 2026, up 29.3% from 0.76 a year earlier and up 5.1% from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Arcutis Biotherapeutics came in at 0.96, up 68.9% from FY2024.
- In earlier years, Asset Utilization Ratio was 0.57 in FY2024 (+277.7%), 0.15 in FY2023 and 0.01 in FY2022.
- The Q2 2026 figure marks the highest quarterly Asset Utilization Ratio in data going back to Q3 2022.
- Compared with a year earlier, Asset Utilization Ratio has increased for nine straight quarters, with growth averaging 113.9% over the last eight quarters.
- The year-over-year growth in Asset Utilization Ratio has ranged between 29.3% (Q2 2026) and 759.1% (Q2 2024) over the last five years.
- Per Business Quant data, ARQT's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.93 (Q1 2026), 0.94 (Q4 2025) and 0.88 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 0.45 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 0.47 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.31 |
| 10 | Arcutis Biotherapeutics | 3.53 Bn | 2.65 Bn | 131.46 Mn | 1.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.00 |
| Jun 30, 2026 | 0.98 |
| Mar 31, 2026 | 0.93 |
| Dec 31, 2025 | 0.94 |
| Sep 30, 2025 | 0.88 |
| Jun 30, 2025 | 0.76 |
| Mar 31, 2025 | 0.61 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.26 |
| Dec 31, 2023 | 0.19 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
API Access
Arcutis Biotherapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();